Matrix metalloproteinases in stem cell regulation and cancer

Kai Kessenbrock, Chih Yang Wang, Zena Werb

Research output: Contribution to journalReview article

103 Citations (Scopus)

Abstract

Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this intriguing family of extracellular proteinases has been implicated in various processes of developmental biology. However, the pathogenic roles of MMPs in human diseases such as cancer have also garnered widespread attention. The most straightforward explanation for their role in cancer is that MMPs, through extracellular matrix degradation, pave the way for tumor cell invasion and metastasis. While this notion may be true for many circumstances, we now know that, depending on the context, MMPs may employ additional modes of functionality. Here, we will give an update on the function of MMPs in development and cancer, which may directly regulate signaling pathways that control tissue homeostasis and may even work in a non-proteolytic manner. These novel findings about the functionality of MMPs have important implications for MMP inhibitor design and may allow us to revisit MMPs as drug targets in the context of cancer and other diseases.

Original languageEnglish
Pages (from-to)184-190
Number of pages7
JournalMatrix Biology
Volume44-46
DOIs
Publication statusPublished - May 1 2015
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Matrix Metalloproteinases
Neoplasms
Developmental Biology
Matrix Metalloproteinase Inhibitors
Amphibians
Morphogenesis
Extracellular Matrix
Larva
Homeostasis
Peptide Hydrolases
Neoplasm Metastasis
Enzymes
Pharmaceutical Preparations

Keywords

  • Cancer
  • Cell differentiation
  • Hemopexin domain
  • Invasion
  • Stem cell niche

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Matrix metalloproteinases in stem cell regulation and cancer. / Kessenbrock, Kai; Wang, Chih Yang; Werb, Zena.

In: Matrix Biology, Vol. 44-46, 01.05.2015, p. 184-190.

Research output: Contribution to journalReview article

Kessenbrock, Kai ; Wang, Chih Yang ; Werb, Zena. / Matrix metalloproteinases in stem cell regulation and cancer. In: Matrix Biology. 2015 ; Vol. 44-46. pp. 184-190.
@article{a0b2fcffb54f4406a293969c5ded8c7d,
title = "Matrix metalloproteinases in stem cell regulation and cancer",
abstract = "Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this intriguing family of extracellular proteinases has been implicated in various processes of developmental biology. However, the pathogenic roles of MMPs in human diseases such as cancer have also garnered widespread attention. The most straightforward explanation for their role in cancer is that MMPs, through extracellular matrix degradation, pave the way for tumor cell invasion and metastasis. While this notion may be true for many circumstances, we now know that, depending on the context, MMPs may employ additional modes of functionality. Here, we will give an update on the function of MMPs in development and cancer, which may directly regulate signaling pathways that control tissue homeostasis and may even work in a non-proteolytic manner. These novel findings about the functionality of MMPs have important implications for MMP inhibitor design and may allow us to revisit MMPs as drug targets in the context of cancer and other diseases.",
keywords = "Cancer, Cell differentiation, Hemopexin domain, Invasion, Stem cell niche",
author = "Kai Kessenbrock and Wang, {Chih Yang} and Zena Werb",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.matbio.2015.01.022",
language = "English",
volume = "44-46",
pages = "184--190",
journal = "Matrix Biology",
issn = "0945-053X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Matrix metalloproteinases in stem cell regulation and cancer

AU - Kessenbrock, Kai

AU - Wang, Chih Yang

AU - Werb, Zena

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this intriguing family of extracellular proteinases has been implicated in various processes of developmental biology. However, the pathogenic roles of MMPs in human diseases such as cancer have also garnered widespread attention. The most straightforward explanation for their role in cancer is that MMPs, through extracellular matrix degradation, pave the way for tumor cell invasion and metastasis. While this notion may be true for many circumstances, we now know that, depending on the context, MMPs may employ additional modes of functionality. Here, we will give an update on the function of MMPs in development and cancer, which may directly regulate signaling pathways that control tissue homeostasis and may even work in a non-proteolytic manner. These novel findings about the functionality of MMPs have important implications for MMP inhibitor design and may allow us to revisit MMPs as drug targets in the context of cancer and other diseases.

AB - Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this intriguing family of extracellular proteinases has been implicated in various processes of developmental biology. However, the pathogenic roles of MMPs in human diseases such as cancer have also garnered widespread attention. The most straightforward explanation for their role in cancer is that MMPs, through extracellular matrix degradation, pave the way for tumor cell invasion and metastasis. While this notion may be true for many circumstances, we now know that, depending on the context, MMPs may employ additional modes of functionality. Here, we will give an update on the function of MMPs in development and cancer, which may directly regulate signaling pathways that control tissue homeostasis and may even work in a non-proteolytic manner. These novel findings about the functionality of MMPs have important implications for MMP inhibitor design and may allow us to revisit MMPs as drug targets in the context of cancer and other diseases.

KW - Cancer

KW - Cell differentiation

KW - Hemopexin domain

KW - Invasion

KW - Stem cell niche

UR - http://www.scopus.com/inward/record.url?scp=84930763579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930763579&partnerID=8YFLogxK

U2 - 10.1016/j.matbio.2015.01.022

DO - 10.1016/j.matbio.2015.01.022

M3 - Review article

C2 - 25661772

AN - SCOPUS:84930763579

VL - 44-46

SP - 184

EP - 190

JO - Matrix Biology

JF - Matrix Biology

SN - 0945-053X

ER -